BREAST CANCER The 21-gene recurrence score - biology remains at the forefront

被引：3
|
作者：
Puhalla, Shannon L. [1 ]
Davidson, Nancy E. [1 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Dept Med, 5150 Ctr Ave, Pittsburgh, PA 15232 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2016年 / 13卷 / 08期
关键词：
DISTANT RECURRENCE; EXPRESSION; THERAPY; WOMEN; RISK;
D O I：
10.1038/nrclinonc.2016.98
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The 21-gene recurrence score is a genetic assay developed to estimate the likelihood of distant recurrence in patients with oestrogen-receptor-positive, lymph-node-negative breast cancer treated with adjuvant endocrine therapy. Now, two studies explore how the 21-gene recurrence score has been used to inform treatment decisions in this setting and beyond.
引用
收藏
页码：470 / 472
页数：2
相关论文
共 50 条
  • [11] Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer
    Rutter, Charles E.
    Yao, Xiaopan
    Mancini, Brandon R.
    Aminawung, Jenerius A.
    Chagpar, Anees B.
    Saglam, Ozlen
    Hofstatter, Erin W.
    Abu-Khalaf, Maysa
    Gross, Cary P.
    Evans, Suzanne B.
    CLINICAL BREAST CANCER, 2016, 16 (01) : 59 - 62
  • [12] Metabolic syndrome and breast cancer recurrence within the 21-gene recurrence score assay.
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, Norah Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [13] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, N. Lynn
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 597 - 603
  • [14] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Jeanette Muniz
    Kelley M. Kidwell
    N. Lynn Henry
    Breast Cancer Research and Treatment, 2016, 157 : 597 - 603
  • [15] Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?
    Yap, Kelly Khai Li
    Koc, Melissa
    Lu, Janice M.
    Spicer, Darcy V.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [16] The Relationship between Recurrence Score of 21-Gene Assay and Clinicopathological Factors of Breast Cancer
    Woolf, K.
    Wang, J.
    Hicks, D. G.
    Wang, X.
    Shciffhauer, L. M.
    Skinner, K.
    Tang, P.
    LABORATORY INVESTIGATION, 2010, 90 : 79A - 79A
  • [17] The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer with Favorable Prognosis
    Turashvili, Gulisa
    Brogi, Edi
    Morrow, Monica
    Wiszowaty, Alicja
    Dickler, Maura
    Norton, Larry
    Hudis, Clifford
    Wen, Hannah Y.
    MODERN PATHOLOGY, 2017, 30 : 74A - 74A
  • [18] Recurrence Score of 21-Gene Assay Is Correlated with a Panel of Immunopathological Factors of Breast Cancer
    Subik, K.
    Delaney, A.
    Wang, J.
    Wang, X.
    Schiffhaner, L. M.
    Shayne, M.
    Huston, A.
    Skinner, K.
    Hicks, D. G.
    Tang, P.
    LABORATORY INVESTIGATION, 2010, 90 : 74A - 74A
  • [19] Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer
    Yang, Shi-Ping
    Liu, Ke
    Li, Yang
    Li, Guan-Qiao
    Li, Jia-Yi
    Lin, Yu-Yi
    Wu, San-Gang
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (1-2) : 99 - 106
  • [20] The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis
    Gulisa Turashvili
    Edi Brogi
    Monica Morrow
    Clifford Hudis
    Maura Dickler
    Larry Norton
    Hannah Y. Wen
    Breast Cancer Research and Treatment, 2017, 165 : 65 - 76
12345